CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 21 enrolled
Drug / intervention
Quetiapine +1 moredrug
Likely dose
Quetiapine 200mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00564564
NCT00564564Phase 4Completed
CompareCT.gov

Quetiapine Augmentation Versus Clomipramine Augmentation of Selective Serotonin Reuptake Inhibitors for Obsessive-compulsive Disorder Patients That do Not Respond to a SSRI Trial: a Randomized Open-trial.

University of Sao Paulo·interventional·Posted Nov 28, 2007·Updated Oct 27, 2017

In Brief

A Phase 4 clinical trial evaluating Quetiapine and Clomipramine for Obsessive Compulsive Disorder. Completed, enrolled 21 participants across 1 site.

Detailed Summary

The objective of this trial is to compare in an open trial format the efficacy of association of clomipramine and quetiapine with SSRI after SSRI treatment failed to produce complete remission of obsessive compulsive disorder symptoms.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObsessive Compulsive Disorder
CountriesBrazil
CollaboratorsConselho Nacional de Desenvolvimento Científico e Tecnológico

Timeline

Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 28, 2007
Enrollment StartJan 1, 2006
Primary CompletionDec 1, 2007
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 18.6 years ago

Interventions

Quetiapinedrug

Quetiapine once a day at maximum dosage of 200mg per day asociated to a SSRI (maximum dosage of 40mg per day for fluoxetine; 200mg per day for sertraline and 60mg per day for citalopram)

Clomipraminedrug

Clomipramine once a day at maximum dosage of 75mg per day plus SSRI (maximum dosage of 40mg per day for fluoxetine; 200mg per day for sertraline and 60mg per day for citalopram)